|
1
|
Antika L, Meilawati L, Dewi R, Tasfiyati A, Septama A. Scopoletin: Anticancer potential and mechanism of action. Asian Pac J Trop Biomed 2023. [DOI: 10.4103/2221-1691.367685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
|
|
2
|
Antika LD, Tasfiyati AN, Hikmat H, Septama AW. Scopoletin: a review of its source, biosynthesis, methods of extraction, and pharmacological activities. Z NATURFORSCH C 2022; 77:303-316. [PMID: 35218175 DOI: 10.1515/znc-2021-0193] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2021] [Accepted: 01/22/2022] [Indexed: 12/24/2022]
Abstract
Scopoletin, also known as 6-methoxy-7 hydroxycoumarin, is one of the naturally occurring coumarin commonly found in many edible plants and plays an important role in human health. Despite the various potential pharmacological properties, the biosynthesis process, method of extraction, and mechanism of action on this compound have not been documented well. In this current review, the biosynthesis pathway, distribution of scopoletin in the plant kingdom, and extraction techniques are elaborated. The in vitro, in vivo, and in silico pharmacological studies are also discussed on antioxidant, antimicrobial, anticancer, anti-inflammation, and neuroprotective aspects of scopoletin. This study may help to understand the benefit of scopoletin containing plants and would be beneficial for the prevention and treatment of diseases.
Collapse
Affiliation(s)
- Lucia Dwi Antika
- Research Center for Chemistry, National Research and Innovation Agency of Indonesia, PUSPIPTEK Area Serpong, Tangerang Selatan, Banten 15314, Indonesia
| | - Aprilia Nur Tasfiyati
- Research Center for Chemistry, National Research and Innovation Agency of Indonesia, PUSPIPTEK Area Serpong, Tangerang Selatan, Banten 15314, Indonesia
| | - Hikmat Hikmat
- Research Center for Chemistry, National Research and Innovation Agency of Indonesia, PUSPIPTEK Area Serpong, Tangerang Selatan, Banten 15314, Indonesia
| | - Abdi Wira Septama
- Research Center for Chemistry, National Research and Innovation Agency of Indonesia, PUSPIPTEK Area Serpong, Tangerang Selatan, Banten 15314, Indonesia
| |
Collapse
|
|
3
|
Culurciello R, Bosso A, Di Fabio G, Zarrelli A, Arciello A, Carella F, Leonardi L, Pazzaglia L, De Vico G, Pizzo E. Cytotoxicity of an Innovative Pressurised Cyclic Solid-Liquid (PCSL) Extract from Artemisia annua. Toxins (Basel) 2021; 13:toxins13120886. [PMID: 34941723 PMCID: PMC8706793 DOI: 10.3390/toxins13120886] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Revised: 11/30/2021] [Accepted: 12/08/2021] [Indexed: 11/21/2022] Open
Abstract
Therapeutic treatments with Artemisia annua have a long-established tradition in various diseases due to its antibacterial, antioxidant, antiviral, anti-malaria and anti-cancer effects. However, in relation to the latter, virtually all reports focused on toxic effects of A. annua extracts were obtained mostly through conventional maceration methods. In the present study, an innovative extraction procedure from A. annua, based on pressurised cyclic solid–liquid (PCSL) extraction, resulted in the production of a new phytocomplex with enhanced anti-cancer properties. This extraction procedure generated a pressure gradient due to compressions and following decompressions, allowing to directly perform the extraction without any maceration. The toxic effects of A. annua PCSL extract were tested on different cells, including three cancer cell lines. The results of this study clearly indicate that the exposure of human, murine and canine cancer cells to serial dilutions of PCSL extract resulted in higher toxicity and stronger propensity to induce apoptosis than that detected by subjecting the same cells to Artemisia extracts obtained through canonical extraction by maceration. Collected data suggest that PCSL extract of A. annua could be a promising and economic new therapeutic tool to treat human and animal tumours.
Collapse
Affiliation(s)
- Rosanna Culurciello
- Department of Biology, University of Naples Federico II, 80126 Naples, Italy; (R.C.); (A.B.); (F.C.)
| | - Andrea Bosso
- Department of Biology, University of Naples Federico II, 80126 Naples, Italy; (R.C.); (A.B.); (F.C.)
| | - Giovanni Di Fabio
- Department of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy; (G.D.F.); (A.Z.); (A.A.)
| | - Armando Zarrelli
- Department of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy; (G.D.F.); (A.Z.); (A.A.)
- Center for Studies on Bioinspired Agro-Environmental Technology (BAT CENTER), University of Naples Federico II, 80126 Naples, Italy
| | - Angela Arciello
- Department of Chemical Sciences, University of Naples Federico II, 80126 Naples, Italy; (G.D.F.); (A.Z.); (A.A.)
| | - Francesca Carella
- Department of Biology, University of Naples Federico II, 80126 Naples, Italy; (R.C.); (A.B.); (F.C.)
| | - Leonardo Leonardi
- Department of Veterinary Medicine—Veterinary Pathology, University of Perugia, 06129 Perugia, Italy;
| | - Laura Pazzaglia
- Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy;
| | - Gionata De Vico
- Department of Biology, University of Naples Federico II, 80126 Naples, Italy; (R.C.); (A.B.); (F.C.)
- Correspondence: (G.D.V.); (E.P.)
| | - Elio Pizzo
- Department of Biology, University of Naples Federico II, 80126 Naples, Italy; (R.C.); (A.B.); (F.C.)
- Correspondence: (G.D.V.); (E.P.)
| |
Collapse
|
|
4
|
Abate G, Zhang L, Pucci M, Morbini G, Mac Sweeney E, Maccarinelli G, Ribaudo G, Gianoncelli A, Uberti D, Memo M, Lucini L, Mastinu A. Phytochemical Analysis and Anti-Inflammatory Activity of Different Ethanolic Phyto-Extracts of Artemisia annua L. Biomolecules 2021; 11:biom11070975. [PMID: 34356599 PMCID: PMC8301839 DOI: 10.3390/biom11070975] [Citation(s) in RCA: 45] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Revised: 06/26/2021] [Accepted: 06/29/2021] [Indexed: 02/06/2023] Open
Abstract
Artemisia annua L. (AA) has shown for many centuries important therapeutic virtues associated with the presence of artemisinin (ART). The aim of this study was to identify and quantify ART and other secondary metabolites in ethanolic extracts of AA and evaluate the biological activity in the presence of an inflammatory stimulus. In this work, after the extraction of the aerial parts of AA with different concentrations of ethanol, ART was quantified by HPLC and HPLC-MS. In addition, anthocyanins, flavanols, flavanones, flavonols, lignans, low-molecular-weight phenolics, phenolic acids, stilbenes, and terpenes were identified and semi-quantitatively determined by UHPLC-QTOF-MS untargeted metabolomics. Finally, the viability of human neuroblastoma cells (SH-SY5Y) was evaluated in the presence of the different ethanolic extracts and in the presence of lipopolysaccharide (LPS). The results show that ART is more concentrated in AA samples extracted with 90% ethanol. Regarding the other metabolites, only the anthocyanins are more concentrated in the samples extracted with 90% ethanol. Finally, ART and all AA samples showed a protective action towards the pro-inflammatory stimulus of LPS. In particular, the anti-inflammatory effect of the leaf extract of AA with 90% ethanol was also confirmed at the molecular level since a reduction in TNF-α mRNA gene expression was observed in SH-SY5Y treated with LPS.
Collapse
Affiliation(s)
- Giulia Abate
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Leilei Zhang
- Department for Sustainable Food Process, Università Cattolica del Sacro Cuore, 29122 Piacenza, Italy;
| | - Mariachiara Pucci
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Giulia Morbini
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Eileen Mac Sweeney
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Giuseppina Maccarinelli
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Giovanni Ribaudo
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Alessandra Gianoncelli
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Daniela Uberti
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Maurizio Memo
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
| | - Luigi Lucini
- Department for Sustainable Food Process, Università Cattolica del Sacro Cuore, 29122 Piacenza, Italy;
- Correspondence: (L.L.); (A.M.)
| | - Andrea Mastinu
- Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy; (G.A.); (M.P.); (G.M.); (E.M.S.); (G.M.); (G.R.); (A.G.); (D.U.); (M.M.)
- Correspondence: (L.L.); (A.M.)
| |
Collapse
|
|
5
|
Guo YX, Zhang Y, Gao YH, Deng SY, Wang LM, Li CQ, Li X. Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy. Front Pharmacol 2021; 12:639651. [PMID: 34262447 PMCID: PMC8273381 DOI: 10.3389/fphar.2021.639651] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Accepted: 06/16/2021] [Indexed: 12/11/2022] Open
Abstract
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system that is mainly mediated by pathological T-cells. Experimental autoimmune encephalomyelitis (EAE) is a well-known animal model of MS that is used to study the underlying mechanism and offers a theoretical basis for developing a novel therapy for MS. Good therapeutic effects have been observed after the administration of natural compounds and their derivatives as treatments for EAE. However, there has been a severe lag in the research and development of drug mechanisms related to MS. This review examines natural products that have the potential to effectively treat MS. The relevant data were consulted in order to elucidate the regulated mechanisms acting upon EAE by the flavonoids, glycosides, and triterpenoids derived from natural products. In addition, novel technologies such as network pharmacology, molecular docking, and high-throughput screening have been gradually applied in natural product development. The information provided herein can help improve targeting and timeliness for determining the specific mechanisms involved in natural medicine treatment and lay a foundation for further study.
Collapse
Affiliation(s)
- Yu-Xin Guo
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China
| | - Yuan Zhang
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China
| | - Yu-Han Gao
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China
| | - Si-Ying Deng
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China
| | - Li-Mei Wang
- Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Cui-Qin Li
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China
| | - Xing Li
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China
| |
Collapse
|
|
6
|
De Vico G, Martano M, Maiolino P, Carella F, Leonardi L. Expression of transferrin receptor-1 (TFR-1) in canine osteosarcomas. Vet Med Sci 2020; 6:272-276. [PMID: 32239803 PMCID: PMC7397888 DOI: 10.1002/vms3.258] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2019] [Revised: 01/22/2020] [Accepted: 02/19/2020] [Indexed: 12/16/2022] Open
Abstract
Due to high rates of proliferation and DNA synthesis, neoplastic cells have higher requirements of iron than normal cells. For that reason, neoplastic cells have remodelled iron metabolism pathways, over‐expressing genes encoding for iron uptake proteins, among which Transferrin Receptor‐1 (TFR‐1). Accumulating evidence has proven that overexpression of TFR‐1 and high Iron concentration, are both widespread condition of cancer cells, both essential to tumour onset and progression. We studied TFR‐1 and PCNA immunohistochemical expression in fifteen (15) Canine osteoblastic osteosarcomas (COS). After immunohistochemical staining, counting of TFR‐1 positive cells by two independent observers showed that 85%–95% of neoplastic cells were strongly labelled at cytoplasmic level by anti‐TFR‐1 antibody in all examined COS. Furthermore, 70%–80% of neoplastic cells were positively labelled at the nuclear level by PCNA. Surprisingly, about 100% of intratumour vascular endothelial cells were also positive, whereas extratumour vascular endothelial cells were negative. The latter is an interesting finding, as TFR‐1 is usually not expressed in normal vasculature, with the exception of normal brain vascular endothelium, where it allows transport of transferrin, and thus iron, into tissues, suggesting a similar function here to support cancer growth. The early results presented highlight the relevance of TFR‐1 expression in canine OS, suggesting therapies involving both TFR‐1 and Iron metabolisms in dogs with osteosarcoma should be developed.
Collapse
Affiliation(s)
- Gionata De Vico
- Department of Biology, University of Naples Federico II, Complesso universitario di Monte S. Angelo, Naples, Italy
| | - Manuela Martano
- Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy
| | - Paola Maiolino
- Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Naples, Italy
| | - Francesca Carella
- Department of Biology, University of Naples Federico II, Complesso universitario di Monte S. Angelo, Naples, Italy
| | - Leonardo Leonardi
- Department of Veterinary Medicine, University of Perugia, Perugia, Italy
| |
Collapse
|